Cardio-oncology, novel biomarkers, and advances in structural heart disease and arrhythmia management [0.03%]
心血管疾病、新型生物标志物及结构性心脏病和心律失常治疗的新进展
Patrizio Lancellotti,Cécile Oury
Patrizio Lancellotti
Cardiovascular medicine continues to move towards precision-based, individualised patient care, supported by novel biomarkers, refined imaging protocols, and multidisciplinary risk assessment. The studies featured in this issue of Acta Card...
Reducing cardiovascular risk in Belgium through practical and measurable initiatives: a multidisciplinary expert-led call to action [0.03%]
通过实际可行的措施降低比利时的心血管疾病风险：多方专家的行动倡议
Peter R Sinnaeve,Frank Cools,Fabian Demeure et al.
Peter R Sinnaeve et al.
Background: The clinical and economic burden of cardiovascular disease (CVD) in Belgium is substantial. Methods: A programme of practic...
Catheter ablation outcomes in monozygotic twins with Wolff-Parkinson-White syndrome and novel TTN/LRP6 variants [0.03%]
经导管消融治疗狼霍夫-帕金森-怀特综合征单卵双胞胎及新型TTN/LRP6变异的效果
Boping Huang,Zhijun Zhang,Changsheng Ma
Boping Huang
Background: Genetic associations with isolated sporadic Wolff-Parkinson-White syndrome have rarely been reported. We report a rare case of monozygotic twin male children diagnosed with Wolff-Parkinson-White syndrome. ...
Impact of the albumin-bilirubin score on short- and long-term mortality in native and prosthetic valve endocarditis ALBI score and mortality in native and prosthetic valve endocarditis [0.03%]
ALBI评分对首次感染和人工瓣膜感染性心内膜炎短期及长期死亡率的影响
Kadir Bıyıklı,Tezel Kovancı,Barkın Kültürsay et al.
Kadir Bıyıklı et al.
Background: Infective endocarditis (IE), involving both native and prosthetic valves, remains a severe multisystem disease associated with high early and long-term mortality despite advances in antimicrobial therapy and c...
Nailin Gong,Xiaojun Xie
Nailin Gong
From the arrhythmia to the substrate: the role of atrial cardiomyopathy in atrial fibrillation management [0.03%]
从心律失常到心房肌病 substrate：心房肌病在心房颤动管理中的作用
Luigi Gerra,Valeria Dall&#x;Ospedale,Giuseppe Boriani et al.
Luigi Gerra et al.
Presence of anti-cardiac troponin I antibodies (cTnIAb) and their role in the left ventricular remodelling, in patients with acute myocardial infarction [0.03%]
急性心肌梗死患者中抗心脏肌钙蛋白I抗体(cTnIAb)的存在及其在左室重塑中的作用
Andrea Del V González-Rojas,Maite González,José Donis et al.
Andrea Del V González-Rojas et al.
Background: Anti-cardiac troponin I antibodies (cTnIAb) have been demonstrated in patients with acute coronary syndrome (ACS); however, their clinical relevance and impact on patient outcomes remain to be elucidated. ...
Guideline-recommended medical therapy and clinical outcomes in cancer patients with de Novo heart failure [0.03%]
癌症合并新发心力衰竭患者的指南推荐药物治疗及临床预后研究
Fadime Bozduman Habip,Imran Ceren,Yusuf Ziya Sener
Fadime Bozduman Habip
Background and aims: Heart failure (HF) may result from cancer therapy, yet data on guideline-recommended medical therapy (GRMT) in this setting remain limited. We aimed to describe the clinical course of de novo HF in ca...